BRID WADE: Open Payments
NPI 1730796830 · GULF BREEZE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$397 in 22 payments from 9 companies in 2025. Trend: 2023 $97 · 2024 $466 · 2025 $397
Food & beverage: $397
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $79 |
| GlaxoSmithKline, LLC. | 5 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $76 |
| Astellas Pharma US Inc | 2 | $56 |
| Amgen Inc. | 2 | $30 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Novo Nordisk Inc | 1 | $14 |
Products named: MOUNJARO, TRELEGY ELLIPTA, AIRSUPRA, Veozah, XIFAXAN, NEXLETOL, TRINTELLIX, EVENITY.
Industry payments across FL — which companies pay providers there.
